AZD0530, AN INHIBITOR OF SRC KINASES, IN PLATINUM-PRETREATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): A TRIAL OF THE PMH PHASE II CONSORTIUM

被引：0
|
作者：
Laurie, Scott A. [1 ]
Goss, Glenwood D. [1 ]
Shepherd, Frances A. [2 ]
Reaume, Neil [1 ]
Nicholas, Garth [1 ]
Philip, Lindsay [2 ]
Wang, Lisa [2 ]
Oza, Amit [2 ]
Hirsh, Vera [3 ]
Wright, James
Leighl, Natasha [2 ]
机构：
[1] Ottawa Hosp Canc Ctr, Ottawa, ON, Canada
[2] Princess Margaret Hosp, Toronto, ON, Canada
[3] Mcgill Univ Hlth Ctr, Dept Oncol, Montreal, PQ, Canada
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
src kinase inhibitor; non-small cell; Phase II;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1262 / S1262
页数：1
相关论文
共 50 条
  • [1] A phase II trial of the Src kinase inhibitor AZD0530 in patients with metastatic or locally advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma: A trial of the PMH phase II consortium
    Mackay, H.
    Au, H.
    McWhirter, E.
    Alcindor, T.
    Jarvi, A.
    MacAlpine, K.
    Wang, L.
    Wright, J. J.
    Oza, A. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] A phase II trial of the Src kinase inhibitor saracatinib (AZD0530) in patients with metastatic or locally advanced gastric or gastro esophageal junction (GEJ) adenocarcinoma: a trial of the PMH phase II consortium
    Mackay, Helen J.
    Au, Heather J.
    McWhirter, Elaine
    Alcindor, Thierry
    Jarvi, Andrea
    MacAlpine, Katrina
    Wang, Lisa
    Wright, John J.
    Oza, Amit M.
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (03) : 1158 - 1163
  • [3] A phase II trial of the Src kinase inhibitor saracatinib (AZD0530) in patients with metastatic or locally advanced gastric or gastro esophageal junction (GEJ) adenocarcinoma: a trial of the PMH phase II consortium
    Helen J. Mackay
    Heather J. Au
    Elaine McWhirter
    Thierry Alcindor
    Andrea Jarvi
    Katrina MacAlpine
    Lisa Wang
    John J. Wright
    Amit M. Oza
    Investigational New Drugs, 2012, 30 : 1158 - 1163
  • [4] A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium study
    Lara, Primo N., Jr.
    Longmate, Jeff
    Evans, Christopher P.
    Quinn, David I.
    Twardowski, Przemyslaw
    Chatta, Gurkamal
    Posadas, Edwin
    Stadler, Walter
    Gandara, David R.
    ANTI-CANCER DRUGS, 2009, 20 (03) : 179 - 184
  • [5] The Src inhibitor AZD0530 induces autophagy in head and neck squamous cell carcinoma and non-small cell lung cancer cell lines
    Frederick, Barbara
    Helfrich, Barbara
    Fletcher, Ashley
    Raben, David
    CANCER RESEARCH, 2009, 69
  • [6] A phase I/II study of the Src inhibitor saracatinib (AZD0530) in combination with gemcitabine in advanced pancreatic cancer
    Renouf, Daniel J.
    Moore, Malcolm J.
    Hedley, David
    Gill, Sharlene
    Jonker, Derek
    Chen, Eric
    Walde, David
    Goel, Rakesh
    Southwood, Bernadette
    Gauthier, Isabelle
    Walsh, Wendy
    McIntosh, Lynn
    Seymour, Lesley
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (02) : 779 - 786
  • [7] A phase I/II study of the Src inhibitor saracatinib (AZD0530) in combination with gemcitabine in advanced pancreatic cancer
    Daniel J. Renouf
    Malcolm J. Moore
    David Hedley
    Sharlene Gill
    Derek Jonker
    Eric Chen
    David Walde
    Rakesh Goel
    Bernadette Southwood
    Isabelle Gauthier
    Wendy Walsh
    Lynn McIntosh
    Lesley Seymour
    Investigational New Drugs, 2012, 30 : 779 - 786
  • [8] A phase II trial of saracatinib (AZD0530), and oral Src inhibitor, in previously treated metastatic pancreatic cancer
    Messersmith, W. A.
    Nallapareddy, S.
    Arcaroli, J.
    Tan, A.
    Foster, N. R.
    Wright, J. J.
    Picus, J.
    Goh, B. C.
    Hidalgo, M.
    Erlichman, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] The dual specific Src/AbI kinase inhibitor AZD0530 inhibits in vitro growth and induces apoptosis in non-small cell lung cancer lines
    Helfrich, B.
    Frederick, B.
    Raben, D.
    Bunn, P. A.
    EJC SUPPLEMENTS, 2006, 4 (12): : 177 - 177
  • [10] A phase II study of pemetrexed and carboplatin as a salvage therapy for platinum-pretreated patients with non-small cell lung cancer
    Kim, Hyeong Su
    Lee, Gyeong-Won
    Kim, Jung Han
    Kim, Ho Young
    Kwon, Jung Hye
    Song, Hun Ho
    Kim, Hyo Jung
    Jung, Joo Young
    Jang, Geundoo
    Choi, Dae Ro
    Park, Sang Myeon
    Shin, Tae Rim
    Lee, Hee-sung
    Zang, Dae Young
    LUNG CANCER, 2010, 70 (01) : 71 - 76
12345